» Articles » PMID: 29921817

Mitochondria-Targeting Small Molecules Effectively Prevent Cardiotoxicity Induced by Doxorubicin

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2018 Jun 21
PMID 29921817
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Doxorubicin (Dox) is a chemotherapeutic agent widely used for the treatment of numerous cancers. However, the clinical use of Dox is limited by its unwanted cardiotoxicity. Mitochondrial dysfunction has been associated with Dox-induced cardiotoxicity. To mitigate Dox-related cardiotoxicity, considerable successful examples of a variety of small molecules that target mitochondria to modulate Dox-induced cardiotoxicity have appeared in recent years. Here, we review the related literatures and discuss the evidence showing that mitochondria-targeting small molecules are promising cardioprotective agents against Dox-induced cardiac events.

Citing Articles

Small Molecules Targeting Mitochondria: A Mechanistic Approach to Combating Doxorubicin-Induced Cardiotoxicity.

Pal C Cardiovasc Toxicol. 2024; 25(2):216-247.

PMID: 39495464 DOI: 10.1007/s12012-024-09941-7.


Modeling drug-induced mitochondrial toxicity with human primary cardiomyocytes.

Tang X, Liu H, Rao R, Huang Y, Dong M, Xu M Sci China Life Sci. 2023; 67(2):301-319.

PMID: 37864082 DOI: 10.1007/s11427-023-2369-3.


Multiple mitochondria-targeted components screened from Sini decoction improved cardiac energetics and mitochondrial dysfunction to attenuate doxorubicin-induced cardiomyopathy.

Ding X, Zhang Y, Pan P, Long C, Zhang X, Zhuo L Theranostics. 2023; 13(2):510-530.

PMID: 36632225 PMC: 9830424. DOI: 10.7150/thno.80066.


Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity.

Wu B, Leung K, Poon E Int J Mol Sci. 2022; 23(3).

PMID: 35163838 PMC: 8837080. DOI: 10.3390/ijms23031912.


Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway.

Sun L, Wang H, Xu D, Yu S, Zhang L, Li X Bioengineered. 2021; 13(1):48-60.

PMID: 34898356 PMC: 8805895. DOI: 10.1080/21655979.2021.2004980.


References
1.
Kim D, Kim H, Woo E, Hong S, Chae H, Chae S . Inhibitory effects of rosmarinic acid on adriamycin-induced apoptosis in H9c2 cardiac muscle cells by inhibiting reactive oxygen species and the activations of c-Jun N-terminal kinase and extracellular signal-regulated kinase. Biochem Pharmacol. 2005; 70(7):1066-78. DOI: 10.1016/j.bcp.2005.06.026. View

2.
Granados-Principal S, Quiles J, Ramirez-Tortosa C, Sanchez-Rovira P, Ramirez-Tortosa M . Hydroxytyrosol: from laboratory investigations to future clinical trials. Nutr Rev. 2010; 68(4):191-206. DOI: 10.1111/j.1753-4887.2010.00278.x. View

3.
Kimura Y, Okuda H . Effects of naturally occurring stilbene glucosides from medicinal plants and wine, on tumour growth and lung metastasis in Lewis lung carcinoma-bearing mice. J Pharm Pharmacol. 2000; 52(10):1287-95. DOI: 10.1211/0022357001777270. View

4.
Shao Z, Vanden Hoek T, Qin Y, Becker L, Schumacker P, Li C . Baicalein attenuates oxidant stress in cardiomyocytes. Am J Physiol Heart Circ Physiol. 2002; 282(3):H999-H1006. DOI: 10.1152/ajpheart.00163.2001. View

5.
Razavi-Azarkhiavi K, Iranshahy M, Sahebkar A, Shirani K, Karimi G . The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity: A Comprehensive Review. Nutr Cancer. 2016; 68(6):892-917. DOI: 10.1080/01635581.2016.1187280. View